馬仁 相

Prof. 馬仁 相

Sapporo Medical University Center for Medical Education
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
THTokimasa Hida
Tokimasa Hida
TKTakafumi Kamiya
Takafumi Kamiya
AKAkinori Kawakami
Akinori Kawakami
JOJiro Ogino
Jiro Ogino
馬相馬仁 相
馬仁 相
KJKowichi Jimbow
Kowichi Jimbow
Melanogenesis is the biological and biochemical process of melanin and melanosome biosynthesis. Melanin is formed by enzymic reactions of tyrosinase family proteins that convert tyrosine to form brown-black eumelanin and yellow-red pheomelanin within melanosomal compartments in melanocytes, following the cascades of events interacting with a series of autocrine and paracrine signals. Fully melanized melanosomes are delivered to keratinocytes of the skin and hair. The symbiotic relation of a melanocyte and an associated pool of keratinocytes is called epidermal melanin unit (EMU). Microphthalmia-associated transcription factor (MITF) plays a vital role in melanocyte development and differentiation. MITF regulates expression of numerous pigmentation genes for promoting melanocyte differentiation, as well as fundamental genes for maintaining cell homeostasis. Diseases involving alterations of EMU show various forms of pigmentation phenotypes. This review introduces four major topics of melanogenesis cascade that include (1) melanocyte development and differentiation, (2) melanogenesis and intracellular trafficking for melanosome biosynthesis, (3) melanin pigmentation and pigment-type switching, and (4) development of a novel therapeutic approach for malignant melanoma by elucidation of melanogenesis cascade.

1 January 2013 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
馬相馬仁 相
馬仁 相
SIShin-Ichi Imai
Shin-Ichi Imai
NTNorio Takei
Norio Takei
HHHirohito Honda
Hirohito Honda
KMKyoichi Matsumoto
Kyoichi Matsumoto
YKYasuo Kokai
Yasuo Kokai
Background: Alzheimer’s disease (AD) differs from other forms of dementia in its relation to amyloid beta-42. Using a cell culture model we previously identified annexin A5 as an AD biomarker. Plasma level of annexin A5 was significantly higher in AD patients compared to that in control. AD has been identified to share a number of clinical and pathological features with Dementia with Lewy bodies (DLB). The present study was done to examine whether or not plasma annexin A5 is a specific marker for AD, when being compared with the levels of DLB patients. As ApoE gene subtype 4 has been noticed as the probable genetic factor for AD, we also examined and compared ApoE genotype in both AD and DLB. Methods: Blood samples were obtained from 150 patients with AD (aged 77.6 ± 6.5 years), 50 patients of DLB (79.4 ± 5.0) and 279 community-dwelling healthy elderly individuals of comparable age and sex (75.6 ± 8.1). All AD patients met NINCDS-ADRDA criteria and all DLB patients were diagnosed as probable DLB according to the latest consensus diagnostic criteria. Quantification was done using the Chemiluminescent Enzyme Immunoassay Technique using the monoclonal antibodies against annexin A5. DNA genotyping of ApoE was performed by distinguishing unique combinations of Hha1 fragments of PCR-amplified genomic DNA products. Results: The plasma level of annexin A5 was significantly higher in AD patients than in the healthy individuals (control) (P < 0.0001). The plasma annexin A5 level was also significantly higher in DLB patients than in the control group (P < 0.0001). From the ROC curves, the mean areas under the curve were 0.863 and 0.838 for the AD/control and DLB/control, respectively. The rate of ApoE4 carrier status and the frequency of the e4 allele were significantly higher in AD or DLB than in control and there was no significant difference between AD and DLB. Conclusions: These results suggest that both annexin A5 and ApoE4 are common markers for AD and DLB.

15 July 2010 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
MYMami Yamaguchi
Mami Yamaguchi
YKYasuo Kokai
Yasuo Kokai
SIShin‐Ichi Imai
Shin‐Ichi Imai
KUKumiko Utsumi
Kumiko Utsumi
KMKyoichi Matsumoto
Kyoichi Matsumoto
馬相馬仁 相
馬仁 相

12 March 2001 in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
Verified
Journal Article
Closed access
馬相馬仁 相
馬仁 相
CCCarl E Creutz
Carl E Creutz
SGShinsei Gasa
Shinsei Gasa
HOHiroko Ohkawa
Hiroko Ohkawa
TAToyoaki Akino
Toyoaki Akino
YKYoshio Kuroki
Yoshio Kuroki

1 December 2002 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
HOHiroko Ohkawa
Hiroko Ohkawa
馬相馬仁 相
馬仁 相
RSRie Sakai
Rie Sakai
YKYoshio Kuroki
Yoshio Kuroki
EHEri Hashimoto
Eri Hashimoto
TSToshikazu Saito
Toshikazu Saito

1 September 2001 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
馬相馬仁 相
馬仁 相
HOHiroko Ohkawa
Hiroko Ohkawa
TAToyoaki Akino
Toyoaki Akino
YKYoshio Kuroki
Yoshio Kuroki
To identify lung lamellar body (LB)-binding proteins, the fractions binding to LB-Se-pharose 4B in a Ca2+-dependent manner from the lung soluble fractions were analyzed with Mono Q column. Four annexins (annexins III, IV, V, and VIII) were identified by partial amino acid sequence analyses as the LB-binding proteins in the lung soluble fractions. A control experiment using phospholipid (phosphatidylserine/phosphatidylg-lycerol/phosphtidylcholine) liposome-Sepharose 4B revealed that annexins III, IV and V were the Ca2+-dependent proteins binding to the column in the lung soluble fractions, while annexin Vlll was not detected. Thus, annexin VJJJ might preferentially bind to LB. On the other hand, the only Ca2+-dependent LB-binding protein identified in the bron-choalveolar lavage fluids was annexin V. It was further demonstrated that annexin V was secreted by isolated alveolar type II cells from rats and that the secretion was stimulated by the addition of phorbol ester (PMA), a potent stimulator of surfactant secretion. The PMA-dependent stimulation of annexin V was attenuated by preincubation with surfactant protein-A (SP-A), a potent inhibitor of surfactant secretion. As LB is thought to be an intracellular store of pulmonary surfactant, which is secreted by alveolar type II cells, annexin V is likely to be secreted together with the lamellar body.